Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 58Colonic Neoplasms 24Rectal Neoplasms 22Neoplasms 19Pancreatic Neoplasms 18Neoplasm Metastasis 17Esophageal Neoplasms 9Stomach Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Sarcoma 6Small Cell Lung Carcinoma 5Lung Neoplasms 5Glioma 5Glioblastoma 5Brain Neoplasms 5Neuroblastoma 4Gliosarcoma 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Renal Cell 4Melanoma 3Intestinal Neoplasms 3Gastrointestinal Neoplasms 3Breast Neoplasms 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Sarcoma, Ewing 2Recurrence 2Rectal Diseases 2Ovarian Neoplasms 2Oligodendroglioma 2

Interventions

Gemcitabine 25Cisplatin 19pembrolizumab 11avelumab 10Nivolumab 7Mitomycin 6Carboplatin 6apaziquone 5Paclitaxel 5Vinblastine 4Methotrexate 4Doxorubicin 4Docetaxel 4BCG Vaccine 4vofatamab 3durvalumab 3atezolizumab 3Sunitinib 3Standard of Care 3Sorafenib 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Radiation 3Magnetic Resonance Spectroscopy 3Lapatinib 3Cystectomy 3B701 protein, Human herpesvirus 6 3valrubicin 2rucaparib 2enfortumab vedotin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Urinary Bladder Neoplasms × Irinotecan × Clear all
NCT00089128 2018-07-12

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Medical University of South Carolina

Phase 2 Terminated
16 enrolled 4 charts
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡